Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

In vivo imaging of spinal cord atrophy in neuroinflammatory diseases.

Liu W, Nair G, Vuolo L, Bakshi A, Massoud R, Reich DS, Jacobson S.

Ann Neurol. 2014 Sep;76(3):370-8. doi: 10.1002/ana.24213. Epub 2014 Jul 22.

2.

HTLV-I-associated myelopathy/tropical spastic paraparesis: semiautomatic quantification of spinal cord atrophy from 3-dimensional MR images.

Evangelou IE, Massoud R, Jacobson S.

J Neuroimaging. 2014 Jan-Feb;24(1):74-8. doi: 10.1111/j.1552-6569.2011.00648.x. Epub 2012 Feb 3.

3.

CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis.

Menezes SM, Decanine D, Brassat D, Khouri R, Schnitman SV, Kruschewsky R, López G, Alvarez C, Talledo M, Gotuzzo E, Vandamme AM, Galvão-Castro B, Liblau R, Weyenbergh JV.

J Neuroinflammation. 2014 Jan 29;11:18. doi: 10.1186/1742-2094-11-18.

4.

Atrophy, focal spinal cord lesions and alterations of diffusion tensor imaging (DTI) parameters in asymptomatic virus carriers and patients suffering from human T-lymphotrophic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Vilchez C, Gonzalez-Reinoso M, Cubbison C, Perez-Then E, Roa P, Martínez A, Foerster B, Oviedo J, Stoeter P.

J Neurovirol. 2014 Dec;20(6):583-90. doi: 10.1007/s13365-014-0282-2. Epub 2014 Sep 17.

PMID:
25227931
5.

[Brain and spinal cord magnetic resonance imaging in spastic paraparesis associated to human T-lymphotropic virus].

Cervilla J, Cartier L, García L.

Rev Med Chil. 2006 Aug;134(8):1010-8. Epub 2006 Nov 14. Spanish.

6.

Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.

Gessain A, Mahieux R.

Rev Neurol (Paris). 2012 Mar;168(3):257-69. doi: 10.1016/j.neurol.2011.12.006. Epub 2012 Mar 7. Review.

PMID:
22405461
7.

Brain magnetic resonance imaging white matter lesions are frequent in HTLV-I carriers and do not discriminate from HAM/TSP.

Morgan DJ, Caskey MF, Abbehusen C, Oliveira-Filho J, Araujo C, Porto AF, Santos SB, Orge GO, Joia MJ, Muniz AL, Siqueira I, Glesby MJ, Carvalho E.

AIDS Res Hum Retroviruses. 2007 Dec;23(12):1499-504.

8.

Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.

Grassi MF, Olavarria VN, Kruschewsky Rde A, Mascarenhas RE, Dourado I, Correia LC, de Castro-Costa CM, Galvão-Castro B.

J Med Virol. 2011 Jul;83(7):1269-74. doi: 10.1002/jmv.22087.

PMID:
21567429
9.

[Neurological symptoms and disability in HTLV-1 associated myelopathy].

Carod-Artal FJ, Mesquita HM, Ribeiro Lda S.

Neurologia. 2008 Mar;23(2):78-84. Spanish.

PMID:
18322825
10.

Monitoring the HTLV-1 proviral load in the peripheral blood of asymptomatic carriers and patients with HTLV-associated myelopathy/tropical spastic paraparesis from a Brazilian cohort: ROC curve analysis to establish the threshold for risk disease.

Furtado Mdos S, Andrade RG, Romanelli LC, Ribeiro MA, Ribas JG, Torres EB, Barbosa-Stancioli EF, Proietti AB, Martins ML.

J Med Virol. 2012 Apr;84(4):664-71. doi: 10.1002/jmv.23227.

PMID:
22337307
11.
12.

Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I.

Puccioni-Sohler M, Yamano Y, Rios M, Carvalho SM, Vasconcelos CC, Papais-Alvarenga R, Jacobson S.

Neurology. 2007 Jan 16;68(3):206-13.

PMID:
17224575
13.
14.

Incidence and clinical significances of human T-cell lymphotropic virus type I-associated myelopathy with T2 hyperintensity on spinal magnetic resonance images.

Yukitake M, Takase Y, Nanri Y, Kosugi M, Eriguchi M, Yakushiji Y, Okada R, Mizuta H, Kuroda Y.

Intern Med. 2008;47(21):1881-6. Epub 2008 Nov 4.

15.

HAM/TSP: association between white matter lesions on magnetic resonance imaging, clinical and cerebrospinal fluid findings.

Puccioni-Sohler M, Gasparetto E, Cabral-Castro MJ, Slatter C, Vidal CM, Cortes RD, Rosen BR, Mainero C.

Arq Neuropsiquiatr. 2012 Apr;70(4):246-51.

16.

Therapeutic strategies in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Nakamura T, Nishiura Y, Eguchi K.

Cent Nerv Syst Agents Med Chem. 2009 Jun;9(2):137-49. Review.

PMID:
20021347
17.

Brain volume measurements in patients with human T-cell lymphotropic virus-1-associated tropical spastic paraparesis.

Griffith C, Bagnato F, Gupta S, Calabrese A, Oh U, Chiu A, Ohayon JM, McAuliffe MJ, Tasciyan TA, Jacobson S.

J Neurovirol. 2006 Oct;12(5):349-55.

PMID:
17065127
18.

Temporal lesions and widespread involvement of white matter associated with multi-organ inflammatory disease in human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Mendes GB, Kalil RS, Rosadas C, de Freitas MR, Puccioni-Sohler M.

Int J Infect Dis. 2014 Aug;25:1-3. doi: 10.1016/j.ijid.2014.03.1374. Epub 2014 May 6.

19.

Abnormalities of spinal magnetic resonance images implicate clinical variability in human T-cell lymphotropic virus type I-associated myelopathy.

Umehara F, Nose H, Saito M, Fukuda M, Ogino M, Toyota T, Yuhi T, Arimura K, Osame M.

J Neurovirol. 2007 Jun;13(3):260-7.

PMID:
17613716
20.

Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.

Goon PK, Igakura T, Hanon E, Mosley AJ, Barfield A, Barnard AL, Kaftantzi L, Tanaka Y, Taylor GP, Weber JN, Bangham CR.

J Immunol. 2004 Feb 1;172(3):1735-43.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk